Thousands of children and families with type 1 diabetes to receive access to CGM technology

The Federal Government has announced its $54 million Continuous Glucose Monitoring (CGM) subsidy initiative as a life-changer for thousands of Australian children, young people and families living with type 1 diabetes.

The CGM subsidy initiative is a significant investment in type 1 diabetes technology and will benefit around 4,000 Australian families with a child or young person living with type 1 diabetes.

Continuous glucose monitors are small wearable devices that can sound alarms and send warnings if glucose levels are getting too low or too high. The devices reduce the number of daily finger prick checks. They can often be used in conjunction with an insulin pump, which routinely delivers insulin.

CGMs can prevent or reduce the risk of hypoglycaemia (low blood sugar) and reduces the risk of diabetes-related complications.

Diabetes Australia will continue to advocate for expansion of CGM access to all ages and further funding to ensure access to this technology is available for those in need.

To access the eligibility form , which includes the full list of eligibility criteria, visit www.ndss.com.au/cgm

Definitioner

Type 1 diabetes

Also known as insulin dependent diabetes, occurs when the pancreas stops making insulin. Requires daily insulin injections for survival.

NDSS

The National Diabetes Services Scheme (NDSS) is a Federal Government funded initiative, administered on behalf of the Government by Diabetes Australia. For further information see Advocacy and Support.